Malcolm D Kearns1, Jessica A Alvarez, Natan Seidel, Vin Tangpricha. 1. Division of Endocrinology, Metabolism and Lipids (MDK, JAA, NS, VT), Emory University School of Medicine, Atlanta, Georgia; and Section of Endocrinology (VT), Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
Abstract
BACKGROUND: Observational studies have linked vitamin D status and infectious disease. This association is supported by the presence of the vitamin D receptor and CYP27B1 in immune cells. This review aims to consolidate data from clinical trials that used vitamin D for the treatment or prevention of infectious disease. METHODS: The authors searched the term "(vitamin D OR ergocalciferol OR cholecalciferol OR vitamin D2 OR vitamin D3 OR calcitriol) AND (infection OR tuberculosis OR sepsis OR pneumonia)" with limits preset to manuscripts published in English and with human subjects. They identified controlled trials that measured infectious outcomes (eg, incidence and severity of disease, time to disease resolution or recurrence, measures of clinical improvement, mortality). Studies that used analog, topical or micronutrient formulations of vitamin D, assessed only vitamin D status or lacked a comparison group were excluded. The references from eligible manuscripts and from 2 recent reviews were scanned for additional manuscripts. RESULTS: One thousand two hundred eighty-four manuscripts were identified with our search terms, with 60 papers still eligible after review of the title and abstract. Full review of these papers, their references and 2 related reviews yielded 38 manuscripts. CONCLUSIONS: Although some prospective studies show positive results regarding vitamin D on infectious disease, several robust studies are negative. Factors such as high variability between studies, the difference in individual responsiveness to vitamin D and study designs that do not primarily investigate infectious outcomes may mask the effects of vitamin D on infections.
BACKGROUND: Observational studies have linked vitamin D status and infectious disease. This association is supported by the presence of the vitamin D receptor and CYP27B1 in immune cells. This review aims to consolidate data from clinical trials that used vitamin D for the treatment or prevention of infectious disease. METHODS: The authors searched the term "(vitamin D OR ergocalciferol OR cholecalciferol OR vitamin D2 OR vitamin D3 OR calcitriol) AND (infection OR tuberculosis OR sepsis OR pneumonia)" with limits preset to manuscripts published in English and with human subjects. They identified controlled trials that measured infectious outcomes (eg, incidence and severity of disease, time to disease resolution or recurrence, measures of clinical improvement, mortality). Studies that used analog, topical or micronutrient formulations of vitamin D, assessed only vitamin D status or lacked a comparison group were excluded. The references from eligible manuscripts and from 2 recent reviews were scanned for additional manuscripts. RESULTS: One thousand two hundred eighty-four manuscripts were identified with our search terms, with 60 papers still eligible after review of the title and abstract. Full review of these papers, their references and 2 related reviews yielded 38 manuscripts. CONCLUSIONS: Although some prospective studies show positive results regarding vitamin D on infectious disease, several robust studies are negative. Factors such as high variability between studies, the difference in individual responsiveness to vitamin D and study designs that do not primarily investigate infectious outcomes may mask the effects of vitamin D on infections.
Authors: An Lehouck; Chantal Mathieu; Claudia Carremans; Femke Baeke; Jan Verhaegen; Johan Van Eldere; Brigitte Decallonne; Roger Bouillon; Marc Decramer; Wim Janssens Journal: Ann Intern Med Date: 2012-01-17 Impact factor: 25.391
Authors: Ilkka Laaksi; Juha-Petri Ruohola; Pentti Tuohimaa; Anssi Auvinen; Riina Haataja; Harri Pihlajamäki; Timo Ylikomi Journal: Am J Clin Nutr Date: 2007-09 Impact factor: 7.045
Authors: Armin Zittermann; Sabine Frisch; Heiner K Berthold; Christian Götting; Joachim Kuhn; Knut Kleesiek; Peter Stehle; Heinrich Koertke; Reiner Koerfer Journal: Am J Clin Nutr Date: 2009-03-25 Impact factor: 7.045
Authors: Adrian R Martineau; Robert J Wilkinson; Katalin A Wilkinson; Sandra M Newton; Beate Kampmann; Bridget M Hall; Geoffrey E Packe; Robert N Davidson; Sandra M Eldridge; Zoë J Maunsell; Sandra J Rainbow; Jacqueline L Berry; Christopher J Griffiths Journal: Am J Respir Crit Care Med Date: 2007-04-26 Impact factor: 21.405
Authors: Adrian R Martineau; Katalin A Wilkinson; Sandra M Newton; R Andres Floto; Anthony W Norman; Keira Skolimowska; Robert N Davidson; Ole E Sørensen; Beate Kampmann; Christopher J Griffiths; Robert J Wilkinson Journal: J Immunol Date: 2007-06-01 Impact factor: 5.422
Authors: Ahmed S Safwat; Ahmad Hasanain; Ahmed Shahat; Mostafa AbdelRazek; Hazem Orabi; Samir K Abdul Hamid; Amany Nafee; Sally Bakkar; Mohamed Sayed Journal: World J Urol Date: 2018-10-25 Impact factor: 4.226
Authors: Lorenzo P Menzel; Willam Ruddick; Mobaswar H Chowdhury; David C Brice; Ryan Clance; Emily Porcelli; Lisa K Ryan; Jungnam Lee; Özlem Yilmaz; Keith L Kirkwood; Laura McMahon; Amy Tran; Gill Diamond Journal: J Periodontal Res Date: 2019-02-25 Impact factor: 3.946
Authors: Franz J J Rieder; Charlotte Gröschel; Marie-Theres Kastner; Karin Kosulin; Johannes Laengle; Rene Zadnikar; Rodrig Marculescu; Martina Schneider; Thomas Lion; Michael Bergmann; Enikö Kallay; Christoph Steininger Journal: J Steroid Biochem Mol Biol Date: 2016-08-09 Impact factor: 4.292